{"url":"https://whatshealthyandwhy.com/leaky-gut/intestinal-permeability","path":"/leaky-gut/intestinal-permeability","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/leaky-gut/intestinal-permeability.json","markdown":"https://whatshealthyandwhy.com/leaky-gut/intestinal-permeability.md"},"topic":{"slug":"leaky-gut","name":"Gut Permeability (Leaky Gut)","url":"https://whatshealthyandwhy.com/leaky-gut"},"slug":"intestinal-permeability","order":1,"title":"Intestinal Permeability","question":"Is leaky gut real, and does it cause disease?","answer":"Leaky gut may contribute to autoimmune and inflammatory disease, but evidence is mostly lab, animal and review-based, and cause versus effect is unsettled.","description":"How tight junctions work, what zonulin does, and why increased intestinal permeability matters for systemic health","confidence":2,"confidenceNote":"An ex vivo biopsy study, animal models and reviews of over 200 studies; cause versus consequence remains unresolved.","evidenceSummary":{"rctCount":0,"metaAnalysisCount":0,"replicated":false,"newestStudyYear":2017},"category":{"categoryTitle":"Your Body","categorySlug":"your-body","subcategoryName":"Body Systems","subcategorySlug":"systems","url":"https://whatshealthyandwhy.com/explore/your-body/systems"},"actions":["Limit known barrier disruptors: alcohol, a Western diet with emulsifiers, chronic stress and, when possible, NSAIDs [3].","Manage stress and ask a doctor about suspected bacterial overgrowth (SIBO), since both can loosen the gut barrier [2][3]."],"cautions":["Not all gastroenterologists accept leaky gut as a clinical diagnosis; the debate is whether permeability causes or results from disease [2][3].","The gliadin result came from biopsy tissue in Ussing chambers, not from people eating gluten [1].","Not a substitute for medical care for celiac disease, IBD or autoimmune conditions."],"simpleText":"The lining of your intestine is only one cell thick, and the spaces between those cells are sealed by structures called tight junctions. When those junctions loosen, particles that should stay inside the gut — undigested food proteins, bacterial fragments, toxins — can slip into the bloodstream. Your immune system treats them as threats, triggering inflammation that can affect the entire body [3]. This process, known as increased intestinal permeability or \"leaky gut,\" is increasingly recognized as a factor in autoimmune disease, food sensitivities, and chronic inflammation.","mediumText":"Tight junctions: the gatekeepers\n\nThe intestinal epithelium is designed to be selectively permeable — absorbing nutrients while keeping everything else out. This selectivity depends on tight junction proteins (claudins, occludins, and zonula occludens) that form a dynamic seal between adjacent epithelial cells. These junctions are not static; they constantly open and close in response to signals from the gut environment [2].\n\nZonulin: the molecule that opens the gates\n\nZonulin is a protein discovered by Dr. Alessio Fasano at the University of Maryland (now at Harvard/Massachusetts General Hospital) that modulates tight junction permeability. When zonulin is released, it binds to receptors on the epithelial surface and triggers a signaling cascade that disassembles tight junction proteins, increasing the space between cells [2].\n\nTwo well-documented triggers of zonulin release:\n\n1. Gliadin — the prolamine protein in gluten. Drago et al. (2006) demonstrated that gliadin triggers zonulin release in intestinal tissue from both celiac and non-celiac individuals, though the response is amplified in celiac patients [1].\n2. Pathogenic bacteria — small intestinal bacterial overgrowth (SIBO) and certain gram-negative bacteria can stimulate zonulin secretion.\n\nWhat happens when the barrier breaks down\n\nWhen intestinal permeability increases beyond normal physiological levels, the consequences cascade:\n\n- Immune activation. Bacterial lipopolysaccharides (LPS) and undigested food proteins cross into the lamina propria and bloodstream. The immune system mounts an inflammatory response against these \"foreign\" molecules [3].\n- Systemic inflammation. Elevated LPS in the blood (endotoxemia) triggers toll-like receptor 4 (TLR4) signaling, producing pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta. This low-grade chronic inflammation affects tissues far from the gut.\n- Food sensitivities. When intact food proteins encounter the immune system in the bloodstream (where they do not belong), the body can develop IgG-mediated responses to those foods — creating sensitivities that may not have existed before the barrier was compromised.\n- Autoimmune triggers. Mu et al. (2017) reviewed the evidence linking leaky gut to autoimmune diseases including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. They proposed that increased permeability is a necessary precondition — along with genetic susceptibility and an environmental trigger — for autoimmune disease development [4].\n\nThe controversy\n\nNot all conventional gastroenterologists accept \"leaky gut\" as a clinical diagnosis. However, the underlying science — intestinal permeability, zonulin signaling, barrier dysfunction — is published extensively in peer-reviewed journals including Physiological Reviews, The Lancet, and Gastroenterology [2][3]. The debate is less about whether increased permeability exists (it does) and more about whether it is a cause or consequence of disease. Fasano's work suggests it can be both.\n\nOther known disruptors of the intestinal barrier include NSAIDs (ibuprofen, aspirin), chronic alcohol use, stress, dysbiosis, and environmental toxins.","deepText":"Drago et al. (2006) conducted ex vivo experiments using intestinal biopsy tissue from both celiac and non-celiac patients, exposing them to gliadin in Ussing chambers. They demonstrated that gliadin induced zonulin release and increased intestinal permeability in both groups within 30 minutes of exposure. The permeability increase was significantly greater in celiac mucosa compared to non-celiac controls, but the finding that gliadin affects permeability even in non-celiac tissue was significant. They measured transepithelial electrical resistance (TEER) as a marker of tight junction integrity and confirmed the results with lactulose-mannitol permeability testing. This study provided direct experimental evidence that gluten can compromise barrier function beyond the celiac population [1].\n\nFasano (2011) published a comprehensive review in Physiological Reviews tracing the discovery and characterization of zonulin as the only known physiological modulator of intercellular tight junctions. He described the signaling pathway: zonulin binds to the epidermal growth factor receptor (EGFR) and protease-activated receptor 2 (PAR2) on the apical surface of enterocytes, activating phospholipase C, which leads to protein kinase C-alpha-mediated disassembly of the tight junction complex. Fasano proposed a three-legged model for autoimmune disease development: genetic predisposition, environmental trigger, and loss of intestinal barrier function. His review compiled evidence from celiac disease, type 1 diabetes, and other autoimmune conditions demonstrating elevated serum zonulin levels and increased permeability as consistent features preceding disease onset [2].\n\nBischoff et al. (2014) published a comprehensive consensus report in BMC Gastroenterology arguing that intestinal permeability should be recognized as a therapeutic target. They reviewed evidence from over 200 studies documenting the role of barrier dysfunction in conditions including irritable bowel syndrome, inflammatory bowel disease, celiac disease, colorectal cancer, type 1 and type 2 diabetes, obesity, metabolic syndrome, chronic fatigue syndrome, depression, and allergic diseases. They provided standardized methods for measuring permeability (lactulose-mannitol ratio, serum zonulin, LPS-binding protein) and identified modifiable factors that impair barrier function: diet (Western diet, alcohol, emulsifiers), medications (NSAIDs, proton pump inhibitors), stress, and dysbiosis [3].\n\nMu et al. (2017) reviewed the mechanistic links between intestinal permeability and autoimmune disease in Clinical Reviews in Allergy and Immunology. They presented evidence that barrier dysfunction precedes autoimmune onset in animal models of type 1 diabetes, multiple sclerosis, and lupus. In human studies, first-degree relatives of patients with autoimmune diseases show increased permeability before developing clinical disease themselves. The authors described how microbial translocation through a compromised barrier activates dendritic cells and macrophages, which then present self-antigens in an inflammatory context, breaking immune tolerance. They concluded that restoring barrier integrity represents a viable therapeutic strategy for preventing or treating autoimmune conditions [4].","deepTruncated":false,"references":[{"id":"1","title":"Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines","authors":"Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A","year":2006,"journal":"Scandinavian Journal of Gastroenterology","pmid":"16635908","url":"https://pubmed.ncbi.nlm.nih.gov/16635908/"},{"id":"2","title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","authors":"Fasano A","year":2011,"journal":"Physiological Reviews","pmid":"21248165","url":"https://pubmed.ncbi.nlm.nih.gov/21248165/"},{"id":"3","title":"Intestinal permeability — a new target for disease prevention and therapy","authors":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM","year":2014,"journal":"BMC Gastroenterology","pmid":"25407511","url":"https://pubmed.ncbi.nlm.nih.gov/25407511/"},{"id":"4","title":"Leaky Gut As a Danger Signal for Autoimmune Diseases","authors":"Mu Q, Kirby J, Reilly CM, Luo XM","year":2017,"journal":"Frontiers in Immunology","pmid":"28588585","url":"https://pubmed.ncbi.nlm.nih.gov/28588585/"}],"wordCount":939,"source":{"path":"src/content/topics/leaky-gut/intestinal-permeability.md"},"citeAs":"“Is leaky gut real, and does it cause disease?.” What's Healthy and Why. https://whatshealthyandwhy.com/leaky-gut/intestinal-permeability","notice":"General information backed by peer-reviewed research, not medical advice."}